Brief: Catalyst Pharmaceuticals Q4 Revenue USD 110.6 Million Vs. IBES Estimate USD 105.9 Million

Catalyst Pharmaceuticals

28/02/2024 23:04

Feb 28 (Reuters) - Catalyst Pharmaceuticals Q4 adjusted net income USD 223.2
million.
* Q4 operating income USD 41.7 million
* Q4 net income USD 71.4 million
* outlook FY revenue USD 455-475 million